On Sunday, Biotech firm LianBio announced the pricing details for its IPO. Why that’s interesting: LianBio is based in New Jersey, but its business is focused on in-licensing, development, and commercialization of therapeutics in Greater China. ICYMI: Wall Street IPOs of Chinese companies have been …